40,193 Shares in Relx Plc $RELX Bought by Vise Technologies Inc.

Vise Technologies Inc. purchased a new position in Relx Plc (NYSE:RELX) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 40,193 shares of the technology company’s stock, valued at approximately $2,184,000.

Several other large investors have also made changes to their positions in RELX. Bleakley Financial Group LLC raised its stake in Relx by 1.5% during the 1st quarter. Bleakley Financial Group LLC now owns 14,147 shares of the technology company’s stock valued at $713,000 after purchasing an additional 207 shares during the period. Venturi Wealth Management LLC boosted its stake in Relx by 1.0% in the 2nd quarter. Venturi Wealth Management LLC now owns 24,476 shares of the technology company’s stock worth $1,330,000 after purchasing an additional 232 shares during the period. Whipplewood Advisors LLC grew its holdings in Relx by 15.7% during the 2nd quarter. Whipplewood Advisors LLC now owns 1,719 shares of the technology company’s stock valued at $93,000 after buying an additional 233 shares in the last quarter. Cynosure Group LLC grew its stake in Relx by 3.5% during the first quarter. Cynosure Group LLC now owns 6,951 shares of the technology company’s stock valued at $350,000 after acquiring an additional 236 shares in the last quarter. Finally, Bridgewater Advisors Inc. lifted its position in shares of Relx by 2.1% in the first quarter. Bridgewater Advisors Inc. now owns 11,463 shares of the technology company’s stock worth $617,000 after buying an additional 238 shares in the last quarter. 15.02% of the stock is currently owned by hedge funds and other institutional investors.

Relx Price Performance

Shares of RELX opened at $42.45 on Wednesday. The company has a 50 day moving average of $45.80 and a two-hundred day moving average of $49.99. The company has a debt-to-equity ratio of 2.55, a quick ratio of 0.42 and a current ratio of 0.47. Relx Plc has a twelve month low of $41.64 and a twelve month high of $56.33.

Analysts Set New Price Targets

A number of brokerages have commented on RELX. Wall Street Zen downgraded shares of Relx from a “buy” rating to a “hold” rating in a research note on Saturday. Barclays reissued an “overweight” rating on shares of Relx in a research note on Tuesday, October 7th. Kepler Capital Markets raised Relx from a “hold” rating to a “strong-buy” rating in a research report on Thursday, September 18th. Morgan Stanley reiterated an “overweight” rating on shares of Relx in a report on Thursday, September 11th. Finally, Weiss Ratings restated a “buy (b)” rating on shares of Relx in a research note on Wednesday, October 8th. One analyst has rated the stock with a Strong Buy rating and five have issued a Buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Buy”.

About Relx

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.